作者
Mohammad Saeedi, Muhammad S Nezhad, Fatemeh Mehranfar, Mahdieh Golpour, Mohammad A Esakandari, Zahra Rashmeie, Maryam Ghorbani, Fatemeh Nasimi, Seyed N Hoseinian
发表日期
2021/1/1
来源
Current Pharmaceutical Biotechnology
卷号
22
期号
2
页码范围
200-215
出版商
Bentham Science Publishers
简介
Mesenchymal Stem Cells (MSCs), a form of adult stem cells, are known to have a selfrenewing property and the potential to specialize into a multitude of cells and tissues such as adipocytes, cartilage cells, and fibroblasts. MSCs can migrate and home to the desired target zone where inflammation is present. The unique characteristics of MSCs in repairing, differentiation, regeneration, and the high capacity of immune modulation have attracted tremendous attention for exerting them in clinical purposes, as they contribute to the tissue regeneration process and anti-tumor activity. The MSCs-based treatment has demonstrated remarkable applicability towards various diseases such as heart and bone malignancies, and cancer cells. Importantly, genetically engineered MSCs, as a stateof- the-art therapeutic approach, could address some clinical hurdles by systemic secretion of cytokines and other agents with a short …
引用总数
202020212022202320241332
学术搜索中的文章